Fluence Energy Stock Performance and Recent Corporate Developments
Market Activity (24‑Hour Period Ending 23 Nov 2026)
- Fluence Energy (FLNC) closed the period at USD 5.59, up 1.18 %.
- The average daily trading volume for the last 24 hours was USD 22.4 million.
- Shares outstanding: 143.2 million.
- Market capitalization: USD 1.1 billion.
- Year‑to‑date trend: Since the end of last month the share price has declined 17.47 %.
- Technical indicators:
- 200‑day simple moving average: USD 16.06.
- 52‑week high: USD 33.51 (30 Jan 2026).
- 52‑week low: USD 5.66 (20 Oct 2026).
Recent Corporate Announcement
Fluence Energy announced a multi‑year battery‑supply agreement with EVE Power.
- The contract is designed to secure a stable supply of battery cells for Fluence’s expanding storage portfolio.
- It aims to improve delivery planning and pricing predictability, supporting the company’s expansion of renewable‑powered storage systems across Europe.
- The partnership follows similar large‑scale battery projects by utilities such as RWE’s 400‑MW plant in the Netherlands and EVN’s 300‑MW target by 2030, reflecting a broader industry shift toward flexible storage solutions.
- Fluence expects the agreement to enhance integration of batteries into wind and solar projects, thereby contributing to grid stability as renewable penetration increases.
- The deal aligns with the storage provider’s broader strategy to synchronize supply chains with rising project volumes and market demand for flexibility services.
Comparative Stock Performance (24‑Hour Period)
| Company | Ticker | % Change | Current Price (USD) | Market Capitalization (USD) | P/E Ratio |
|---|---|---|---|---|---|
| Adient | ADNT | +0.41 % | 16.6 | 1.3 bn | 28.5 |
| Cricut | CRCT | –2.31 % | 6.25 | 1.3 bn | 15.43 |
| Damora Therapeutics | DMRA | +4.16 % | 21.09 | 1.3 bn | – |
| Rex American | REX | –2.40 % | 39.83 | 1.3 bn | 11.19 |
| Nektar Therapeutics | NKTR | +0.99 % | 37.22 | 1.3 bn | – |
Additional Note – Cricut: Cricut filed a Form 144 on 21 Oct 2026, disclosing a planned sale of 180,000 Class A shares by senior officer Ashish Arora. The sale will be executed through Goldman Sachs & Co. LLC under a Rule 10b5‑1 plan adopted on 20 Aug 2025. The filing lists prior transactions within the past three months, providing transparency on the officer’s equity disposition.
Additional Note – Damora Therapeutics: Damora reported a modest rise in net asset value in Q3, supported by U.S. drug approvals for several portfolio companies and acquisitions by Vertex Pharmaceuticals and GSK. The firm added twelve new positions and divested eight, narrowing the discount of share price to net asset value.
Additional Note – Rex American: Rex American’s role in the peptide industry has been highlighted in recent commentary. While peptide medicines are best known for weight‑loss applications, sales are increasingly driven by treatments for other diseases and non‑prescription products such as skincare and supplements. The company focuses on manufacturing and delivery within the peptide value chain, positioning it to benefit from broader adoption of peptide technologies, although manufacturing constraints and regulatory delays remain potential challenges.
Company Overview
Fluence Energy, Inc. is headquartered in Arlington, United States, and operates in the industrial sector. The company specializes in energy storage technology solutions, offering a portfolio that includes products, services, digital applications, and an AI‑powered IQ platform designed to optimize renewable and third‑party storage assets. Fluence’s global operations and focus on AI integration position it to support renewable‑energy deployment and grid stability. More information is available on the company’s website, www.fluenceenergy.com , and it is listed on the Nasdaq stock exchange.
